Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Stockholders' Equity

v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
August 2025 Offering [Member]
December 2025 PIPE Financing [Member]
Common Stock
Common Stock
August 2025 Offering [Member]
Common Stock
December 2025 PIPE Financing [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
August 2025 Offering [Member]
Additional Paid-in Capital [Member]
December 2025 PIPE Financing [Member]
Accumulated Other Comprehensive (Loss) [Member]
Retained Earnings [Member]
Balance as of beginning of period (in shares) at Dec. 31, 2023       492,223              
Balance as of beginning of period at Dec. 31, 2023 $ 68,340     $ 2     $ 425,471     $ (96) $ (357,037)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options (in shares) 3,000     3,390              
Issuance of common stock upon exercise of stock options $ 315           315        
Stock-based compensation (in shares)       32,156              
Stock-based compensation 11,810           11,810        
Issuance of common stock and warrants in connection with capital raise, net of issuance costs (in shares)       114,830              
Issuance of common stock and warrants in connection with capital raise, net of issuance costs 4,239           4,239        
Issuance of common stock in connection with debt extinguishment (in shares)       12,343,423              
Issuance of common stock in connection with debt extinguishment 24,608     $ 2     24,606        
Reclassifications and adjustments due to rounding impact from reverse stock split for fractional shares (in shares)       7,940              
Net loss (69,744)                   (69,744)
Other comprehensive loss 96                 $ 96  
Balance as of end of period (in shares) at Dec. 31, 2024       12,993,962              
Balance as of end of period at Dec. 31, 2024 39,664     $ 4     466,441       (426,781)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (25,014)                    
Balance as of end of period at Mar. 31, 2025 32,801                    
Balance as of beginning of period (in shares) at Dec. 31, 2024       12,993,962              
Balance as of beginning of period at Dec. 31, 2024 39,664     $ 4     466,441       (426,781)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (38,277)                    
Balance as of end of period at Jun. 30, 2025 21,373                    
Balance as of beginning of period (in shares) at Dec. 31, 2024       12,993,962              
Balance as of beginning of period at Dec. 31, 2024 39,664     $ 4     466,441       (426,781)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (49,465)                    
Balance as of end of period at Sep. 30, 2025 29,913                    
Balance as of beginning of period (in shares) at Dec. 31, 2024       12,993,962              
Balance as of beginning of period at Dec. 31, 2024 $ 39,664     $ 4     466,441       (426,781)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options (in shares) 0                    
Issuance of common stock upon vesting of RSUs (in shares)       254,543              
Stock-based compensation (in shares)       0              
Stock-based compensation $ 9,509           9,509        
Issuance of common stock and warrants in connection with capital raise, net of issuance costs (in shares)         6,708,333 3,636,363          
Issuance of common stock and warrants in connection with capital raise, net of issuance costs   $ 17,823 $ 27,967   $ 1     $ 17,822 $ 27,967    
Issuance of common stock in connection with warrant cancellation (in shares)       990,159              
Issuance of common stock in connection with warrant cancellation 14,555           14,555        
Reclassifications and adjustments due to rounding impact from reverse stock split for fractional shares (in shares)       24,270              
Net loss (71,362)                   (71,362)
Balance as of end of period (in shares) at Dec. 31, 2025       24,607,630              
Balance as of end of period at Dec. 31, 2025 38,156     $ 5     $ 536,294       $ (498,143)
Balance as of beginning of period at Mar. 31, 2025 32,801                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (13,263)                    
Balance as of end of period at Jun. 30, 2025 21,373                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (11,188)                    
Balance as of end of period at Sep. 30, 2025 $ 29,913